Chemotherapy toxicity and quality of life in older women with advanced or recurrent endometrial cancer: An NRG Oncology - Gynecologic Oncology Group ancillary study

被引：0
|
作者：
Ko, E. M. [1 ]
Java, J. [2 ]
Van Le, L. [3 ]
Schmitz, K. [4 ]
Randall, M. E. [5 ]
Bloss, J. D. [6 ]
Fleming, G. [7 ]
Moore, D. H. [8 ]
Monk, B. J. [9 ]
Muss, H. B. [10 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Gynecol Oncol Grp, Stat & Data Ctr, Buffalo, NY USA
[3] Univ N Carolina, Chapel Hill, NC USA
[4] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[5] Univ Kentucky, Med Ctr, Lexington, KY USA
[6] Astella Pharma, Northbrook, IL USA
[7] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[8] Franciscan Phys Network Gynecol Oncol Specialists, Indianapolis, IN USA
[9] Univ Arizona, Ctr Canc, Phoenix, AZ USA
[10] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
来源：
GYNECOLOGIC ONCOLOGY | 2015年 / 137卷
关键词：
D O I：
10.1016/j.ygyno.2015.01.075
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
73
引用
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [21] Chemotherapy Completion in Elderly Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer-An NRG Oncology/Gynecologic Oncology Group Study
    不详
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2017, 72 (08) : 481 - 482
  • [22] Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study
    Hamilton, C. A.
    Miller, A.
    Casablanca, Y.
    Horowitz, N. S.
    Rungruang, B.
    Krivak, T. C.
    Richard, S. D.
    Rodriguez, N.
    Birrer, M. J.
    Backes, F. J.
    Geller, M. A.
    Quinn, M.
    Goodheart, M. J.
    Mutch, D. G.
    Kavanagh, J. J.
    Maxwell, G. L.
    Bookman, M. A.
    GYNECOLOGIC ONCOLOGY, 2018, 148 (02) : 275 - 280
  • [23] Effects of the WRITE Symptoms interventions on symptom and quality-of-life outcomes for women with recurrent ovarian cancer. GOG-259: An NRG Oncology/Gynecologic Oncology Group study
    Donovan, H. S.
    Sereika, S.
    Edwards, R. P.
    Bender, C. S.
    Given, B.
    Hughes, S. H.
    Klein, S.
    Knapp, J.
    Nolte, S.
    Roberge, M. C.
    Spring, M. B.
    Wenzel, L.
    Ward, S. E.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 25 - 26
  • [24] Receipt of adjuvant endometrial cancer treatment updates according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study
    Felix, Ashley S.
    Cohn, David E.
    Brasky, Theodore M.
    Zaino, Richard
    Park, Kay
    Mutch, David G.
    Creasman, William T.
    Thaker, Premal H.
    Walker, Joan L.
    Moore, Richard G.
    Lele, Shashikant B.
    Guntupalli, Saketh R.
    Downs, Levi S.
    Nagel, Christa, I
    Boggess, John F.
    Pearl, Michael L.
    Ioffe, Olga B.
    Randall, Marcus E.
    Brinton, Louise A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 219 (05) : 459.e1 - 459.e11
  • [25] Impact of treatment-induced neutropenia and thrombocytopenia on survival in patients with advanced ovarian cancer treated with chemotherapy plus bevacizumab: An NRG Oncology/Gynecologic Oncology Group ancillary data study
    Tewari, K. S.
    Java, J.
    Eskander, R. N.
    Monk, B. J.
    Burger, R. A.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 25 - 26
  • [26] Phase II trial of danazol in advanced, recurrent, or persistent endometrial cancer: a Gynecologic Oncology Group study
    Covens, A
    Brunetto, VL
    Markman, M
    Orr, JW
    Lentz, SS
    Benda, J
    GYNECOLOGIC ONCOLOGY, 2003, 89 (03) : 470 - 474
  • [27] Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study
    Felix, A. S.
    Brasky, T. M.
    Cohn, D. E.
    Mutch, D. G.
    Creasman, W. T.
    Thaker, P. H.
    Walker, J. L.
    Moore, R. G.
    Lele, S. B.
    Guntupalli, S. R.
    Downs, L. S.
    Nagel, Ci
    Boggess, J. F.
    Pearl, M. L.
    Ioffe, O. B.
    Deng, W.
    Miller, D. S.
    Brinton, L. A.
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (06) : 1102 - 1115
  • [28] MULTIDRUG TREATMENT OF ADVANCED AND RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    COHEN, CJ
    BRUCKNER, HW
    DEPPE, G
    BLESSING, JA
    HOMESLEY, H
    LEE, JH
    WATRING, W
    OBSTETRICS AND GYNECOLOGY, 1984, 63 (05): : 719 - 726
  • [29] Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology/Gynecologic Oncology Group study
    Tewari, K. S.
    Java, J. J.
    Eskander, R. N.
    Monk, B. J.
    Burger, R. A.
    ANNALS OF ONCOLOGY, 2016, 27 (01) : 114 - 121
  • [30] Complete responses in the irradiated field following treatment with chemotherapy with and without bevacizumab in advanced cervical cancer: An NRG Oncology/Gynecologic Oncology Group study
    Eskander, R. N.
    Java, J.
    Monk, B. J.
    Tewari, K. S.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 28 - 28
12345